Spotlight on Cemiplimab-rwlc in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Focus on Patient Selection and Considerations
Jeffrey Ahn,1 Misako Nagasaka1,2 1Department of Medicine, University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA; 2St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence: Misako Nagasaka, Department of Medicine, University of C...
Main Authors: | Ahn J, Nagasaka M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/spotlight-on-cemiplimab-rwlc-in-the-treatment-of-non-small-cell-lung-c-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
Recent Advances in Immunotherapy in Metastatic NSCLC.
by: Pranshu Bansal, et al.
Published: (2016-11-01) -
Immunotherapy in the treatment of non-small cell lung cancer (NSCLC) - analysis of epidemiology and cure - review
by: Kinga Ruszel, et al.
Published: (2020-08-01) -
Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country
by: Soon Hin How, et al.
Published: (2022-06-01) -
Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer Patients
by: Takeshi Okamoto, et al.
Published: (2023-07-01) -
Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies
by: Thierry Berghmans, et al.
Published: (2021-11-01)